SCHEMBL5745145

SCHEMBL5745145

COC(=O)CN1C(=O)C(Cc2ccc(OC)cc2)Sc2ccc(CO)cc21

nearest known ligand 0.55

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PPARG P37231 5/20 0.55
MCL1 Q07820 1/20 0.43
GAA P10253 1/20 0.42
HSD17B3 P37058 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALDH1A1 P00352 2/20 0.38
LMNA P02545 2/20 0.38
HTT P42858 1/20 0.38
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
KMT2A Q03164 1/20 0.36
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5798279 0.92 PPARG (0.46) PPARGMCL1GAAHSD17B3SMN1; SMN2
SCHEMBL6847175 0.91 PPARG (0.54) PPARGMCL1GAAHSD17B3SMN1; SMN2
SCHEMBL6847051 0.90 PPARG (0.43) PPARGMCL1GAAHSD17B3SMN1; SMN2
SCHEMBL6847052 0.89 PPARG (0.54) PPARGMCL1GAAHSD17B3SMN1; SMN2
SCHEMBL5746078 0.88 PPARG (0.53) PPARGMCL1GAAHSD17B3SMN1; SMN2
SCHEMBL5744982 0.85 PPARG (0.51) PPARGMCL1GAASMN1; SMN2LMNA
SCHEMBL5747320 0.84 PPARG (0.50) PPARGMCL1GAAHSD17B3SMN1; SMN2
SCHEMBL5747345 0.83 PPARG (0.54) PPARGMCL1GAAHSD17B3SMN1; SMN2
SCHEMBL5744163 0.82 MCL1 (0.52) PPARGMCL1GAAHSD17B3SMN1; SMN2
SCHEMBL5747025 0.81 PPARG (0.45) PPARGMCL1GAAHSD17B3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173427-B1 HYDROXAMIC ACID DERIVATIVE DAINIPPON SUMITOMO PHARMA CO (JP) 2006-04-05 EP disclosed
US-6713477-B1 1,4-BENZTHIAZINES OR BENZOXAZINES; MATRIX METALLOPROTEINASE INHIBITORS SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2004-03-30 US disclosed